ロード中...
Anti-HCV drugs in the pipeline
Several directly-acting and host-targeting antivirals that inhibit hepatitis C virus replication have entered clinical trials. Amongst the most advanced of these are RG7128, an inhibitor of the NS5B polymerase; BMS-790052, an inhibitor of NS5A; and alisporivir, an inhibitor of human cyclophilins. Th...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3775341/ https://ncbi.nlm.nih.gov/pubmed/22440918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coviro.2011.10.019 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|